Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Change in Receivables (2019 - 2025)

Historic Change in Receivables for Sanofi (SNYNF) over the last 6 years, with Q4 2025 value amounting to -$1.4 billion.

  • Sanofi's Change in Receivables fell 457672.54% to -$1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.1 billion, marking a year-over-year decrease of 20620.66%. This contributed to the annual value of -$1.4 billion for FY2025, which is 438230.26% down from last year.
  • As of Q4 2025, Sanofi's Change in Receivables stood at -$1.4 billion, which was down 457672.54% from -$29.9 million recorded in Q4 2024.
  • In the past 5 years, Sanofi's Change in Receivables ranged from a high of -$29.9 million in Q4 2024 and a low of -$1.4 billion during Q4 2025
  • Its 4-year average for Change in Receivables is -$521.7 million, with a median of -$328.9 million in 2021.
  • Per our database at Business Quant, Sanofi's Change in Receivables soared by 9410.83% in 2024 and then crashed by 457672.54% in 2025.
  • Over the past 4 years, Sanofi's Change in Receivables (Quarter) stood at -$149.9 million in 2021, then crashed by 238.88% to -$507.8 million in 2023, then skyrocketed by 94.11% to -$29.9 million in 2024, then crashed by 4576.73% to -$1.4 billion in 2025.
  • Its Change in Receivables was -$1.4 billion in Q4 2025, compared to -$29.9 million in Q4 2024 and -$507.8 million in Q4 2023.